The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
Numerous longevity genes have been discovered in model organisms and altering their function results in prolonged lifespan. In mammals, some have speculated that any health benefits derived from manipulating these same pathways might be offset by increased cancer risk on account of their propensity to boost cell survival. The Sir2/SIRT1 family of NAD(+)-dependent deacetylases is proposed to underlie the health benefits of calorie restriction (CR), a diet that broadly suppresses cancer in mammals. Here we show that CR induces a two-fold increase SIRT1 expression in the intestine of rodents and that ectopic induction of SIRT1 in a beta-catenin-driven mouse model of colon cancer significantly reduces tumor formation, proliferation, and animal morbidity in the absence of CR. We show that SIRT1 deacetylates beta-catenin and suppresses its ability to activate transcription and drive cell proliferation. Moreover, SIRT1 promotes cytoplasmic localization of the otherwise nuclear-localized oncogenic form of beta-catenin. Consistent with this, a significant inverse correlation was found between the presence of nuclear SIRT1 and the oncogenic form of beta-catenin in 81 human colon tumor specimens analyzed. Taken together, these observations show that SIRT1 suppresses intestinal tumor formation in vivo and raise the prospect that therapies targeting SIRT1 may be of clinical use in beta-catenin-driven malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“We and other researchers have gathered compelling evidence, from yeast to mammals, supporting the idea that a loss of epigenetic information, resulting in changes in gene expression, leads to the loss of cellular identity [3–7].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325 · cited 1×
“b-catenin is the central effector in the canonical Wnt signaling pathway that controls stem cell maintenance, development and carcinogenesis [20].”
BackgroundActivation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905 · cited 1×
“. Constitutive activation of the β-catenin pathway has been found in 90% of colorectal cancers”
BackgroundModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · cited 1×
“On the other hand, SIRT1 can be proapoptotic [12] and anti-proliferative [13,14], and consequently has been proposed to behave as a tumor suppressor in vivo.”
BackgroundCalorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Self-citationIncreased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis
Brack, A. S., Conboy, M. J., Roy, S., Lee, M., Kuo, C. J., Keller, C., & Rando, T. A. (2007) · Science · doi:10.1126/science.1144090 · Cited by 1,564 · cited 2×
“Interestingly, two recent studies have shown that increased Wnt signaling is associated with accelerated aging, suggesting that an attenuation of Wnt signaling might underlie CR and be beneficial not only for treating cancer but for more broadly attenuating diseases of aging [23,24].”
BackgroundMultiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,357
Self-citationAssociation of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223 · cited 1×
“of the second allele leads to constitutive nuclear localization of bcatenin and adenoma formation [18,19].”
BackgroundSirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart
Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S. F., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000267723.65696.4a · Cited by 1,147
Cited by
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085
Self-citationPrice, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.003 · Cited by 1,602
“Generation of a Whole Body SIRT1 Overexpressor Mouse A Cre-inducible SIRT1 transgenic mice harboring a transcriptional STOP element flanked with loxP sites inserted between a CAGGS promoter and the murine SIRT1 cDNA was described previously (Firestein et al., 2008).”
BackgroundSelf-citationRecent progress in the biology and physiology of sirtuins
Finkel, T., Deng, C.-X., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,484
SIRT1 and other sirtuins in metabolism
Chang, H.-C., & Guarente, L. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.12.001 · Cited by 1,133
“Significantly, several sirtuins have been reported to have tumor suppressing activities: SIRT1 overexpression is sufficient to suppress colon cancer growth in the APCmin/+ model [100].”
BackgroundSelf-citationTherapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
“regulating b-catenin signaling and glycolysis (Firestein et al., 2008; Sebastián et al., 2012).”
Self-citationSIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging
Oberdoerffer, P., Michan, S., McVay, M., Mostoslavsky, R., Vann, J., Park, S.-K., Hartlerode, A., Stegmuller, J., Hafner, A., Loerch, P., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.025 · Cited by 852
“Given that the effects of resveratrol may not be limited to SIRT1 activation, we generated a SIRT1 transgenic mouse strain (SIRT1STOP) that allows for Cre-mediated temporal and tissuespecific overexpression of SIRT1 via the deletion of a transcriptional STOP cassette (Firestein et al., 2008).”
InfluentialSelf-citationImpaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
Wang, R.-H., Sengupta, K., Li, C., Kim, H.-S., Cao, L., Xiao, C., Kim, S., Xu, X., Zheng, Y., Chilton, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.09.001 · Cited by 769
“On the other hand, it was recently demonstrated that increased expression of SIRT1 reduces colon cancer formation in the APCmin/+ mouse model (Firestein et al., 2008).”
InfluentialSirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1α
Lim, J.-H., Lee, Y.-M., Chun, Y.-S., Chen, J., Kim, J.-E., & Park, J.-W. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.023 · Cited by 758
“M SIRT1 deficiency promotes the development of multiple tumors by disrupting genomic stability, and SIRT1 overexpression inhibits the development of colon cancer by deacetylating b-catenin (Wang et al., 2008; Firestein et al., 2008).”
BackgroundSirtuin 1 and Sirtuin 3: Physiological Modulators of Metabolism
Nogueiras, R., Habegger, K. M., Chaudhary, N., Finan, B., Banks, A. S., Dietrich, M. O., Horvath, T. L., Sinclair, D. A., Pfluger, P. T., & Tschöp, M. H. (2012) · Physiological Reviews · doi:10.1152/physrev.00022.2011 · Cited by 711
“In the intestine, SIRT1 is known to suppress intestinal tumorigenesis and colon cancer growth (102).”
BackgroundSelf-citationRegulation of SIRT1 in cellular functions: Role of polyphenols
Chung, S., Yao, H., Caito, S., Hwang, J.-W., Arunachalam, G., & Rahman, I. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.003 · Cited by 650
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
Sebastián, C., Zwaans, B. M. M., Silberman, D. M., Gymrek, M., Goren, A., Zhong, L., Ram, O., Truelove, J., Guimaraes, A. R., Toiber, D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.10.047 · Cited by 660
“Interestingly, SIRT1 has also been involved in colorectal cancer by modulating the activity of b-catenin (Firestein et al., 2008), suggesting that sirtuins might have evolved to regulate different aspects of the tumorigenic process.”
The NAD metabolome — a key determinant of cancer cell biology
Chiarugi, A., Dölle, C., Felici, R., & Ziegler, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3340 · Cited by 639
SIRT1 Mediates Central Circadian Control in the SCN by a Mechanism that Decays with Aging
Chang, H.-C., & Guarente, L. (2013) · Cell · doi:10.1016/j.cell.2013.05.027 · Cited by 615
“RNA in situ hybridization of the SCN also showed that SIRT1 RNA was undetectable in SCN of BSKOmice and overexpressed in SCN of BSTGmice (Figure 1B).”
InfluentialSelf-citationSirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer
Herranz, D., Muñoz-Martin, M., Cañamero, M., Mulero, F., Martinez-Pastor, B., Fernandez-Capetillo, O., & Serrano, M. (2010) · Nature Communications · doi:10.1038/ncomms1001 · Cited by 612
Small molecule SIRT1 activators for the treatment of aging and age-related diseases
Hubbard, B. P., & Sinclair, D. A. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.12.004 · Cited by 569
“Resveratrol slows the growth of numerous other cancers including colon [57], prostate, and lymphoma [58].”
Self-citationEvidence for a common mechanism of SIRT1 regulation by allosteric activators
Hubbard, B. P., Gomes, A. P., Dai, H., Li, J., Case, A. W., Considine, T., Riera, T. V., Lee, J. E., E, S. Y., Lamming, D. W., et al. (2013) · Science · doi:10.1126/science.1231097 · Cited by 561
Self-citation(2011) · PubMed Central · Cited by 560
Metabolism and cancer: the circadian clock connection
Sahar, S., & Sassone-Corsi, P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2747 · Cited by 551
“Furthermore, ectopic induction of SIRT1 suppresses intestinal tumorigenesis and colon cancer growth in vivo”
Backgroundp53 post-translational modification: deregulated in tumorigenesis
Dai, C., & Gu, W. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.09.002 · Cited by 523
SIRT1 Is Essential for Normal Cognitive Function and Synaptic Plasticity
Michan, S., Li, Y., Chou, M. M.-H., Parrella, E., Ge, H., Long, J. M., Allard, J. S., Lewis, K., Miller, M., Xu, W., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0027-10.2010 · Cited by 541
“To increase brain SIRT1 levels, we bred the floxed SIRT1 transgenic mice (Firestein et al., 2008) with the brain-specific Nestin–Cre mice (Tronche et al., 1999).”
BackgroundMethodInfluentialSelf-citationThe multifaceted functions of sirtuins in cancer
Chalkiadaki, A., & Guarente, L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3985 · Cited by 496
Self-citationGuarente, L. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100831 · Cited by 510
Self-citationImpairment of an endothelial NAD(+)-H2S signaling network is a reversible cause of vascular aging
Das, A., Huang, G. X., Bonkowski, M. S., Longchamp, A., Li, C., Schultz, M. B., Kim, L.-J., Osborne, B., Joshi, S., Lu, Y., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.008 · Cited by 496
“REAGENT or RESOURCE SOURCE IDENTIFIER Methocel (viscosity: 4000 cps) Sigma-Aldrich Cat#M0512 BS1 lectin-FITC Sigma-Aldrich Cat#9381 Fetal Bovine Serum (FBS) Life Technologies Cat#10099141 Penicillin/Streptomycin (10,000 U/mL) Life Technologies Cat#15140122 Cytochrome c Oxidase from bovine heart Sigma-Aldrich Cat#C-549…”
InfluentialSelf-citationSong, S. J., Poliseno, L., Song, M. S., Ala, U., Webster, K., Ng, C., Beringer, G., Brikbak, N. J., Yuan, X., Cantley, L. C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.026 · Cited by 491
Calorie restriction and sirtuins revisited
Guarente, L. (2013) · Genes & Development · doi:10.1101/gad.227439.113 · Cited by 464
“One should note for SIRT1, however, that evidence for both a tumor prevention function (e.g., Firestein et al. 2008) and tumor enhancement function in established tumors (e.g., Li et al. 2013) has been reported.”
BackgroundSelf-citationSirtuin activators and inhibitors: Promises, achievements, and challenges
Dai, H., Sinclair, D. A., Ellis, J. L., & Steegborn, C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.004 · Cited by 463
“It is further protective in many murine disease models, including cancer, type 2 diabetes, and cardiovascular disease (Banks et al., 2008; Bordone et al., 2007; Firestein et al., 2008; Hsu et al., 2008; Oberdoerffer et al., 2008; Pfluger et al., 2008; Qin et al., 2006; Ramadori et al., 2011; Satoh et al., 2010).”
BackgroundSelf-citationSirtuin signaling in cellular senescence and aging
Lee, S.-H., Lee, J.-H., Lee, H.-Y., & Min, K.-J. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.1.290 · Cited by 435
“adipose tissue, skeletal muscle, kidney, brain and intestine, (81, 83, 84).”
RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10
Donmez, G., Wang, D., Cohen, D. E., & Guarente, L. (2010) · Cell · doi:10.1016/j.cell.2010.06.020 · Cited by 432
“Recent studies also implicate SIRT1 in tumor protection, at least in somemousemodels (Firestein et al., 2008).”
Self-citationRetractedHow does SIRT1 affect metabolism, senescence and cancer?
Brooks, C. L., & Gu, W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2562 · Cited by 428
“In the Apc Min mouse model of colon cancer, increased SIRT1 levels as a result of ectopic expression or calorie restriction resulted in reduced cell proliferation and tumour formatio”
BackgroundSirtuins — novel therapeutic targets to treat age-associated diseases
Lavu, S., Boss, O., Elliott, P. J., & Lambert, P. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2665 · Cited by 426
“However, recent evidence indicates that SIRT1 can directly inhibit β-catenin, another member of the Wnt signalling pathwa”
BackgroundLi, L., Wang, L., Li, L., Wang, Z., Ho, Y., McDonald, T., Holyoake, T. L., Chen, W., & Bhatia, R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.020 · Cited by 410
“In the Apc+/ mouse model of colon cancer, increased SIRT1 expression resulted in reduced cell proliferation and tumor formation (Firestein et al., 2008).”
BackgroundAre sirtuins viable targets for improving healthspan and lifespan?
Baur, J. A., Ungvari, Z., Minor, R. K., Le Couteur, D. G., & de Cabo, R. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3738 · Cited by 382
Seven sirtuins for seven deadly diseases ofaging
Morris, B. J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.525 · Cited by 377
Calorie restriction and cancer prevention: metabolic and molecular mechanisms
Longo, V. D., & Fontana, L. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.004 · Cited by 378
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis
Wang, R.-H., Zheng, Y., Kim, H.-S., Xu, X., Cao, L., Lahusen, T., Lee, M.-H., Xiao, C., Vassilopoulos, A., Chen, W., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.09.011 · Cited by 359
“However, recent studies revealed that Sirt1 might serve as a tumor suppressor for certain tumor types in mice (Firestein et al., 2008; Wang et al., 2008).”
How ageing processes influence cancer
de Magalhães, J. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3497 · Cited by 367
Mammalian Sirt1: insights on its biological functions
Rahman, S., & Islam, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-11 · Cited by 362
“The data demonstrated that the reduction in tumor development is caused by the ability of Sirt1 to deacetylate b-catenin and promote cytoplasmic localization of the nuclear-localized oncogenic form of b-catenin [26].”
BackgroundSundaresan, N. R., Pillai, V. B., Wolfgeher, D., Samant, S., Vasudevan, P., Parekh, V., Raghuraman, H., Cunningham, J. M., Gupta, M., & Gupta, M. P. (2011) · Science Signaling · doi:10.1126/scisignal.2001465 · Cited by 348
“Induction of SIRT1 by caloric restriction reduces cell proliferation and tumor formation in a mouse model of colon cancer (37).”
BackgroundMetabolic Pathways Regulating Colorectal Cancer Initiation and Progression
La Vecchia, S., & Sebastián, C. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.018 · Cited by 349
SIRT1 and p53, effect on cancer, senescence and beyond
Yi, J., & Luo, J. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.05.002 · Cited by 340
“SIRT1 suppressed intestinal tumorigenesis and colon cancer growth in a β-catenin-driven mouse model of colon cancer [30].”
BackgroundThe Dual Role of Sirtuins in Cancer
Bosch-Presegue, L., & Vaquero, A. (2011) · Genes & Cancer · doi:10.1177/1947601911417862 · Cited by 329
“SirT1 deacetylates β-catenin, which suppresses localization of β-catenin to the nucleus and reduces the ability of β-catenin to activate transcription, suggesting that SirT1 functions as a tumor suppressor.(129) Another important role for SirT1 in cancer is its suppression of the apoptosis inhibitor Survivin in breast…”
BackgroundSIRT1, Is It a Tumor Promoter or Tumor Suppressor?
Deng, C.-X. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.147 · Cited by 321
“growth is driven by active β-catenin [38].”
BackgroundT Cell Replicative Senescence in Human Aging
P. Chou, J., & B. Effros, R. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219711 · Cited by 323
Nosho, K., Irahara, N., Shima, K., Kure, S., Kirkner, G. J., Schernhammer, E. S., Hazra, A., Hunter, D. J., Quackenbush, J., Spiegelman, D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003698 · Cited by 311
Self-citationAging and disease: connections to sirtuins
Donmez, G., & Guarente, L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00548.x · Cited by 311
“Firestein et al. (2008) tested a transgenic gut-specific SIRT1 over-expressing strain of mice in a APCmin ⁄ + model of colon cancer.”
BackgroundSelf-citationRole of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming
Ong, A. L. C., & Ramasamy, T. S. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.02.004 · Cited by 301
Nakagawa, T., & Guarente, L. (2011) · Journal of Cell Science · doi:10.1242/jcs.081067 · Cited by 288
“catenin and the formation of tumors (Firestein et al., 2008).”
BackgroundSelf-citationSirtuins: guardians of mammalian healthspan
Giblin, W., Skinner, M. E., & Lombard, D. B. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.04.007 · Cited by 282
Sirtuins in Epigenetic Regulation
Jing, H., & Lin, H. (2015) · Chemical Reviews · doi:10.1021/cr500457h · Cited by 270
Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer
Talero, E., García-Mauriño, S., Ávila-Román, J., Rodríguez-Luna, A., Alcaide, A., & Motilva, V. (2015) · Marine Drugs · doi:10.3390/md13106152 · Cited by 255
“through deacetylation of β-catenin [115].”
SIRT1: recent lessons from mouse models
Herranz, D., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2962 · Cited by 255
SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β‐catenin
Simic, P., Zainabadi, K., Bell, E., Sykes, D. B., Saez, B., Lotinun, S., Baron, R., Scadden, D., Schipani, E., & Guarente, L. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201606 · Cited by 253
“The above findings suggest that in MSCs, SIRT1 deacetylates b -catenin to trigger its concentration in the nucleus and earlier study in epithelial cells (Firestein et al, 2008) showed that SIRT1 deacetylation of b -catenin exerts the opposite result—eviction of b -catenin from the nucleus.”
Self-citationTranscriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer
Bian, J., Dannappel, M., Wan, C., & Firestein, R. (2020) · Cells · doi:10.3390/cells9092125 · Cited by 250
“NAD-dependent deacetylase sirtuin-1 (SIRT1) inhibits β-catenin transcriptional activity and drives the cytoplasmic transfer of oncogenic β-catenin, which represses colon tumour formation [34].”
BackgroundInfluentialSelf-citationEnergy Balance, Host-Related Factors, and Cancer Progression
Hursting, S. D., & Berger, N. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.27.9935 · Cited by 252
“However, there is also evidence that SIRT1 can act to suppress polyp formation in the APC intestinal tumor model.(105) Additionally, preclinical studies of resveratrol, a phytochemical shown to activate sirtuins, suggest that activation of SIRT1 may be a viable cancer prevention or therapy strategy.”
BackgroundLane, D. P., Cheok, C. F., & Lain, S. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001222 · Cited by 246
Wang, B., Hasan, M. K., Alvarado, E., Yuan, H., Wu, H., & Chen, W. Y. (2011) · Oncogene · doi:10.1038/onc.2010.468 · Cited by 245
Lin, Z., & Fang, D. (2013) · Genes & Cancer · doi:10.1177/1947601912475079 · Cited by 237
Sorting out functions of sirtuins in cancer
Roth, M., & Chen, W. Y. (2014) · Oncogene · doi:10.1038/onc.2013.120 · Cited by 241
The sirtuin family’s role in aging and age-associated pathologies
Hall, J. A., Dominy, J. E., Lee, Y., & Puigserver, P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64094 · Cited by 229
“driven colon cancer model (96), sarcomas, lymphomas, teratomas, and carcinomas arising from deletion of p53 (97), HFD-induced hepatocarcinomas (98), and age-associated spontaneous tumor”
BackgroundSirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer
Jung‐Hynes, B., Reiter, R. J., & Ahmad, N. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00729.x · Cited by 233
“These authors also found an inverse correlation between nuclear SIRT1 and the oncogenic form of b-catenin in human colon tumor specimens [78].”
BackgroundSirtuin regulation in aging and injury
Poulose, N., & Raju, R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.017 · Cited by 236
Regulation of Wnt/β-catenin signaling by posttranslational modifications
Gao, C., Xiao, G., & Hu, J. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-13 · Cited by 226
“The positive role of β-catenin acetylation is further supported by a study showing that the NADdependent deacetylase sirt1 deacetylates β-catenin, leading to inhibition of β-catenin transcriptional activity and cell proliferation [225].”
BackgroundKwon, H.-S., & Ott, M. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.08.001 · Cited by 229
A c-Myc–SIRT1 feedback loop regulates cell growth and transformation
Yuan, J., Minter-Dykhouse, K., & Lou, Z. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200809167 · Cited by 232
“However, recent work with SIRT1 transgenic and knockout mice also suggests a role for SIRT1 in tumor suppression (Firestein et al., 2008; Wang et al., 2008).”
BackgroundInsulin resistance and hyperinsulinaemia in the development and progression of cancer
Godsland, I. F. (2010) · Clinical Science · doi:10.1042/cs20090399 · Cited by 231
Hadanny, A., & Efrati, S. (2020) · Biomolecules · doi:10.3390/biom10060958 · Cited by 204
Small-Molecule Allosteric Activators of Sirtuins
Sinclair, D. A., & Guarente, L. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134657 · Cited by 223
Self-citationPlasma mi RNA s as early biomarkers for detecting hepatocellular carcinoma
Wen, Y., Han, J., Chen, J., Dong, J., Xia, Y., Liu, J., Jiang, Y., Dai, J., Lu, J., Jin, G., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29544 · Cited by 218
SIRT1 Regulates UV-Induced DNA Repair through Deacetylating XPA
Fan, W., & Luo, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.07.006 · Cited by 223
“SIRT1 also promotes cytoplasmic localization of the otherwise nucleus-localized oncogenic form of b-catenin in a b-catenin-driven mouse model of colon cancer and significantly reduces the tumor formation and proliferation (Firestein et al., 2008).”
BackgroundSIRT1 Suppresses the Epithelial-to-Mesenchymal Transition in Cancer Metastasis and Organ Fibrosis
Simic, P., Williams, E. O., Bell, E. L., Gong, J. J., Bonkowski, M., & Guarente, L. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.019 · Cited by 221
“KSTG mice were generated by crossing SIRT1 loxP-flanked mice (Firestein et al., 2008) with mice having Hoxb7cre promoter.”
Self-citationChen, J., Chan, A. W. H., To, K.-F., Chen, W., Zhang, Z., Ren, J., Song, C., Cheung, Y.-S., Lai, P. B. S., Cheng, S.-H., et al. (2013) · Hepatology · doi:10.1002/hep.26278 · Cited by 214
Sirtuins, Aging, and Metabolism
Guarente, L. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010629 · Cited by 202
“Additional murine studies indicated that SIRT1 can be protective against colon cancer (Firestein et al. 2008) and breast cancer (Wang et al. 2008).”
BackgroundSelf-citationCrystal Structures of Human SIRT3 Displaying Substrate-induced Conformational Changes
Jin, L., Wei, W., Jiang, Y., Peng, H., Cai, J., Mao, C., Dai, H., Choy, W., Bemis, J. E., Jirousek, M. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014928 · Cited by 204
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators
Wang, Y., He, J., Liao, M., Hu, M., Li, W., Ouyang, H., Wang, X., Ye, T., Zhang, Y., & Ouyang, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.028 · Cited by 202
Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research
Hursting, S. D., Smith, S. M., Lashinger, L. M., Harvey, A. E., & Perkins, S. N. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp280 · Cited by 205
Dvir-Ginzberg, M., Gagarina, V., Lee, E.-J., & Hall, D. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803196200 · Cited by 201
Jeninga, E. H., Schoonjans, K., & Auwerx, J. (2010) · Oncogene · doi:10.1038/onc.2010.206 · Cited by 193
“In line with this, overexpression of Sirt1 suppresses intestinal tumor formation and growth (Firestein et al., 2008) and the AMPK activator Metformin inhibits the growth of human breast cancer cells (Zakikhani et al.”
BackgroundYamakuchi, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00068 · Cited by 188
Chen, J., Zhang, B., Wong, N., Lo, A. W. I., To, K.-F., Chan, A. W. H., Ng, M. H. L., Ho, C. Y. S., Cheng, S.-H., Lai, P. B. S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4274 · Cited by 188
“Increased SIRT1 expression has been found to reduce tumor formation in a mouse model of colon tumor (27), whereas SIRT1 mutant mice exhibited increased DNA instability and are more susceptible to tumor development (28).”
BackgroundWang, M., Han, D., Yuan, Z., Hu, H., Zhao, Z., Yang, R., Jin, Y., Zou, C., Chen, Y., Wang, G., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-1187-4 · Cited by 186
Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype
Carafa, V., Altucci, L., & Nebbioso, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00038 · Cited by 184
“Resveratrol reduces the proliferation of different cancers (Aggarwal et al., 2004; Firestein et al., 2008).”
BackgroundWnt Signaling Regulates Hepatic Metabolism
Liu, H., Fergusson, M. M., Wu, J. J., Rovira, I. I., Liu, J., Gavrilova, O., Lu, T., Bao, J., Han, D., Sack, M. N., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001249 · Cited by 174
“Furthermore, b-catenin directly interacts with SIRT1 (34).”
InfluentialGlucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
Chocarro-Calvo, A., García-Martínez, J. M., Ardila-González, S., De la Vieja, A., & García-Jiménez, C. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.11.022 · Cited by 179
“SIRT1 deacetylates b-catenin to decrease its oncogenic capacity (Firestein et al., 2008), and SIRT1 depletion, or inhibition using NAA, in cells treated with LiCl mimics glucose-driven nuclear retention of b-catenin for promoting transcriptional activation.”
BackgroundSIRT1 Acts as a Modulator of Neointima Formation Following Vascular Injury in Mice
Li, L., Zhang, H.-N., Chen, H.-Z., Gao, P., Zhu, L.-H., Li, H.-L., Lv, X., Zhang, Q.-J., Zhang, R., Wang, Z., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.237875 · Cited by 179
Rajendran, R., Garva, R., Krstic-Demonacos, M., & Demonacos, C. (2011) · BioMed Research International · doi:10.1155/2011/368276 · Cited by 174
“For example, increased Sirt1 levels have been identified in acute myeloid leukaemia (AML) [202] and colon cancer where Sirt1 might promote proliferation and survival [203] or cell growth inhibition [204].”
Sirtuins and their Biological Relevance in Aging and Age-Related Diseases
Zhao, L., Cao, J., Hu, K., He, X., Yun, D., Tong, T., & Han, L. (2020) · Aging and disease · doi:10.14336/ad.2019.0820 · Cited by 162
“cancer mouse models, sirt1 can protect against the development of intestinal tumors in a β-catenin-driven colon cancer model [147], sarcomas, lymphomas, teratomas, and carcinomas arising from deletion of p53”
BackgroundSirtuins and Disease: The Road Ahead
Carafa, V., Nebbioso, A., & Altucci, L. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00004 · Cited by 178
“Furthermore, some studies have suggested that SirT1 overexpression in APC−/+ mice reduces rather than increases colon cancer formation (Firestein et al., 2008).”
BackgroundBeirowski, B., Gustin, J., Armour, S. M., Yamamoto, H., Viader, A., North, B. J., Michán, S., Baloh, R. H., Golden, J. P., Schmidt, R. E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104969108 · Cited by 174
“Conditional Sirt2-overexpressing mice were engineered analogous to previously reported Sirt1 transgenics using Flp-mediated genomic integration at the Collagen A1 locus (54).”
BackgroundSelf-citationSirtuin Inhibitors as Anticancer Agents
Hu, J., Jing, H., & Lin, H. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.44 · Cited by 169
The emerging role of alternative splicing in senescence and aging
Deschênes, M., & Chabot, B. (2017) · Aging Cell · doi:10.1111/acel.12646 · Cited by 166
“Notably, both suboptimal and excess levels of SIRT1 have a tumor suppressive impact in rodents (Firestein et al., 2008; Kabra et al., 2009).”
BackgroundThe emerging and diverse roles of sirtuins in cancer: a clinical perspective
Chen, W., Yuan, H., & Su, L. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s37750 · Cited by 162
“coli) mouse colon cancer model reduces tumor formation and proliferation.(125) SIRT1+/-p53+/- mice have a higher incidence of tumors than wild-type, SIRT1+/- and p53+/- mice.”
Chen, H.-C., Jeng, Y.-M., Yuan, R.-H., Hsu, H.-C., & Chen, Y.-L. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2159-4 · Cited by 165
“SIRT1 deacetylates b-catenin and promotes cytoplasmic localization of b-catenin to suppress its ability to activate transcription and drive cell proliferation.(17) Our results of negative association of SIRT1 expression and b-catenin mutation support these observations, indicating SIRT1 is more likely to drive tumor p…”
BackgroundInfluentialEpigenetic Regulatory Mechanisms Induced by Resveratrol
Fernandes, G., Silva, G., Pavan, A., Chiba, D., Chin, C., & Dos Santos, J. (2017) · Nutrients · doi:10.3390/nu9111201 · Cited by 161
“The overexpression of SIRT1 showed an antiproliferative effect in CC cell lines [156].”
BackgroundRole of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer
Jung-Hynes, B., Nihal, M., Zhong, W., & Ahmad, N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807869200 · Cited by 165
Inflammatory pathways in the early steps of colorectal cancer development
Mariani, F., Sena, P., & Roncucci, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9716 · Cited by 171
“SIRT1 suppresses intestinal tumorigenesis and colon cancer growth in a β -catenin-driven mouse model of colon cancer [96,97] .”
SirT1 Is an Inhibitor of Proliferation and Tumor Formation in Colon Cancer
Kabra, N., Li, Z., Chen, L., Li, B., Zhang, X., Wang, C., Yeatman, T., Coppola, D., & Chen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000034 · Cited by 157
Mai, A., Valente, S., Meade, S., Carafa, V., Tardugno, M., Nebbioso, A., Galmozzi, A., Mitro, N., De Fabiani, E., Altucci, L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9008289 · Cited by 156
Bae, H. J., Noh, J. H., Kim, J. K., Eun, J. W., Jung, K. H., Kim, M. G., Chang, Y. G., Shen, Q., Kim, S.-J., Park, W. S., et al. (2013) · Oncogene · doi:10.1038/onc.2013.216 · Cited by 166
SIRT1 Deacetylase in SF1 Neurons Protects against Metabolic Imbalance
Ramadori, G., Fujikawa, T., Anderson, J., Berglund, E. D., Frazao, R., Michán, S., Vianna, C. R., Sinclair, D. A., Elias, C. F., & Coppari, R. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.014 · Cited by 158
“These mutants were generated by crossing the Sf1-Cre transgene to the ColA1 allele that has been created by insertion of a loxP-flanked-STOP Sirt1 coding sequence cassette into the 30 end of the ColA1 locus (Firestein et al., 2008).”
MethodSelf-citationJin, L., Galonek, H., Israelian, K., Choy, W., Morrison, M., Xia, Y., Wang, X., Xu, Y., Yang, Y., Smith, J. J., et al. (2009) · Protein Science · doi:10.1002/pro.50 · Cited by 151
Self-citation
Metadata
- Authors
- Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Campbell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., Hahn, W. C., Guarente, L. P., & Sinclair, D. A.
- Affiliations
- Broad Institute (US)
- Massachusetts Institute of Technology (US)
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Sinclair, David A.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-04-16
- Volume
- 3
- Issue
- 4
- Pages
- e2020
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2289879
- OpenAlex
- W2158153532
- Cited by
- 588
- References
- 34
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 12 · 2023: 29 · 2022: 11 · 2021: 25 · 2020: 15 · 2019: 31 · 2018: 37 · 2017: 25 · 2016: 38 · 2015: 31 · 2014: 40 · 2013: 60 · 2012: 46
- FWCI
- 22.92
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-06-06)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Glenn Foundation for Medical Research
- National Space Biomedical Research Institute
- National Institutes of Health (NIH T32)
- National Institute on Aging (R01AG028730, R01AG019719)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- SIRT1, NAD+-dependent deacetylase, caloric restriction, intestinal tumorigenesis, colon cancer, β-catenin, protein deacetylation, cytoplasmic localization, cell proliferation, longevity genes
- MeSH terms
- Animals, Cell Nucleus, Colonic Neoplasms, Humans, Mice, Inbred C57BL, Models, Biological, Rats, Inbred F344, Gene Expression Regulation, Neoplastic, Sirtuins, Cell Proliferation, beta Catenin, Mice, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.